MENU
EXEL
AS OF
Dec 24 closing price
Price
$46.51
Change
-$0.10 (-0.21%)
Capitalization
12.47B
47 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
EXEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Exelixis (EXEL) Ownership - Who owns Exelixis?

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.47B
P/E Ratio
19.54
Total Cash
988.54M
Projected Growth
2.62
Total Debt
176.46M
Revenue
2.29B
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
3.69
Total Debt/Equity
479.87
Revenue/Share
8.00 USD as % of share price

Fundamentals

EXEL
Capitalization
12.5B
P/E Ratio
19.54
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash
989M
Total Cash/Share
3.69
Total Debt
176M
Total Debt/Equity
479.87
Projected Growth (PEG Ratio)
2.62
Revenue/Share (as % of the share price)
8.00%
Revenue
2.29B
ROE
N/A
Book Value
2.16B
P/B Ratio
5.77
Cash Flow
N/A
Earnings
2.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
268K
Current Ratio
3.75
Current Revenue Per Employee
521146.47
Dividends Per Share - Security
N/A
EBITDA
850M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.89
Revenue To Assets
23.44
Shares Held By Institutions
19B
Shares Outstanding - Current
268M
Total Liabilities
663M
Total Volume MTD
N/A
Value
-1
Gain YTD
39.670
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
EXEL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EXEL showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for EXEL
A.I. Advisor
published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com